NEW UPDATE ALERT.....................

Lamotrigine is an antiepileptic medication used to treat epilepsy and mood disorders such as bipolar disorder. The U.S. Food and Drug Administration (FDA) issued a new warning regarding the risk for hemophagocytic lymphohistiocytosis (HLH), which is a rare immune system reaction.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

McGraw-Hill INTERNAL UPDATES FORM

Date:

April 29, 2018

Site:

accesspharmacy.com

Title of Book and Edition:

Pharmacotherapy: A Pathophysiologic Approach, 10th Edition

Author:

DiPiro JT, et al, eds.

Chapter number/chapter title:

Chapter 56: Epilepsy

Location of Update in the chapter:

Treatment, Pharmacologic Therapy

 

Content Update

April 29, 2018

Risk of Hemophagocytic Lymphohistiocytosis with Lamotrigine Use: Lamotrigine is an antiepileptic medication used for management of epilepsy and mood disorders such as bipolar disorder. The U.S. Food and Drug Administration issued a new warning regarding the risk for hemophagocytic lymphohistiocytosis (HLH), which is a rare immune system reaction.

Create a Free MyAccess Profile

AccessMedicine Network is the place to keep up on new releases for the Access products, get short form didactic content, read up on practice impacting highlights, and watch video featuring authors of your favorite books in medicine. Create a MyAccess profile and follow our contributors to stay informed via email updates.